4540.T
4540.T
JP3535800001
TSUMURA & CO
Loading chart...

Company Profile

Tsumura & Co. engages in the production and sale of Kampo extract intermediates and granular Kampo formulations in Japan and internationally. The company offers products for female problems, proneness to fatigue, skin problems, gastrointestinal problems, obesity, constipation and hemorrhoids, as well as body aches, children's sickness, stress, urinary problems, and cold, cough, and nasal/throat inflammation symptoms. It is also involved in manufacturing and sales of prescription drugs and over-the-counter Kampo medicines. In addition, it produces and sells alcoholic beverages and food products. Tsumura & Co. was founded in 1893 and is headquartered in Tokyo, Japan.

Related stocks

4516.T
4516.T • Japan
NIPPON SHINYAKU CO
3,372 JPY
1.44B USD 1Y -0.4%
4887.T
4887.T • Japan
SAWAI GROUP HOLDINGS CO LTD
1,629.5 JPY
1.19B USD 1Y -18.6%
4553.T
4553.T • Japan
TOWA PHARMACEUTICAL CO
3,620 JPY
1.13B USD 1Y +21.7%
4547.T
4547.T • Japan
KISSEI PHARMACEUTICAL CO
3,710 JPY
981.04M USD 1Y -13.4%
4506.T
4506.T • Japan
SUMITOMO PHARMA CO LTD
1,591.5 JPY
4.51B USD 1Y -15.7%
300725.SZ
300725.SZ • China
PHARMABLOCK
51.01 CNY
1.78B USD 1Y +22.3%
600211.SS
600211.SS • China
TIBET RHODIOLA PHARMACEUTICAL H
36.78 CNY
1.77B USD 1Y -22.9%
600216.SS
600216.SS • China
ZHEJIANG MEDICINE
12.59 CNY
1.81B USD 1Y -12.9%

Key Metrics & Overview

Detailed metrics & financial data of the company

Company Profile
5 Metrics

🛡️ Risk & Structural Analysis

Multi-Factor Risk Model & Market Data

7/7 Very High
5Y Volatility
27.8% p.a.
Max Drawdown (5Y)
-34.3%
Sharpe Ratio (5Y)
-0.02
Size Class
Mega Cap
Notes & Warnings
Single Stock Risk: Investing in an individual stock carries full company and insolvency risk (no fund diversification).
Exemplary balance sheet strength: Very solid ratio of equity to debt.
🔴 Low analyst coverage – higher uncertainty in growth estimates & projections
Historical Stress Test: Maximum peak-to-trough drawdown of -50.8% in the extended horizon.
ende